LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine Hydrochloride W/ Epinephrine, and what generic alternatives are available?
Lidocaine Hydrochloride W/ Epinephrine is a drug marketed by Abbott, Bel Mar, Dell Labs, Intl Medication, and Watson Labs. and is included in eight NDAs.
The generic ingredient in LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE?
- What are the global sales for LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE?
- What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE?
Summary for LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 8 |
Clinical Trials: | 218 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE at DailyMed |
![LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE drug patent expirations Drug patent expirations by year for LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE](/p/graph/s/t/LIDOCAINE_HYDROCHLORIDE_W/_EPINEPHRINE-patent-expirations.png)
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Qassim Health Cluster | Phase 3 |
Hospital de San Carlos Dr. Benicio Arzola Medina | Phase 4 |
National Taiwan University Hospital | N/A |
See all LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE clinical trials